A mathematical model of the indirect effects of rotavirus vaccination

European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition Evidence-Based Recommendations for Rotavirus Vaccination in Europe: Executive Summary

(2010) Timo Vesikari et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Estimated mortality and hospital admission due to rotavirus infection in the WHO European region

(2009) C. J. WILLIAMS et al.   EPIDEMIOLOGY AND INFECTION

Live Attenuated Human Rotavirus Vaccine, RIX4414, Provides Clinical Protection in Infants Against Rotavirus Strains With and Without Shared G and P Genotypes

(2009) Beatrice De Vos et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Hospital-Based Surveillance to Estimate the Burden of Rotavirus Gastroenteritis Among European Children Younger Than 5 Years of Age

(2009) J. Forster et al.   PEDIATRICS

Demographic Variability, Vaccination, and the Spatiotemporal Dynamics of Rotavirus Epidemics

(2009) V. E. Pitzer et al.   SCIENCE

Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination

(2009) Eunha Shim et al.   VACCINE

The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe

(2009) Mark Jit et al.   VACCINE

Rotavirus infection in children and adult patients attending in a tertiary Hospital of São Paulo, Brazil

(2008) Emerson Carraro et al.   Brazilian Journal of Infectious Diseases

Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases

(2008) Joël Mossong et al.   PLOS MEDICINE

The cost-utility of rotavirus vaccination with Rotarix™ (RIX4414) in the Netherlands

(2007) Lucas M.A. Goossens et al.   VACCINE

Cost and cost-effectiveness of childhood vaccination against rotavirus in France

(2007) H. Melliez et al.   VACCINE